EcoDrugPlus

Eph Receptor A3

Ensembl ID : ENSUMAG00000001426
Gene Symbol: EPHA3
4 Cross references
215 Possible Orthologues:

Eph Receptor B4

Ensembl ID : ENSUMAG00000010929
Gene Symbol: EPHB4
3 Cross references
166 Possible Orthologues:

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSUMAG00000008214
Gene Symbol: FAU
4 Cross references
168 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSUMAG00000025480
Gene Symbol: FYN
4 Cross references
261 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSUMAG00000011834
Gene Symbol: GPR119
4 Cross references
174 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSUMAG00000010547
Gene Symbol: GPR84
4 Cross references
124 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSUMAG00000000236
Gene Symbol: HCK
4 Cross references
205 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSUMAG00000002680
Gene Symbol: ITK
4 Cross references
207 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSUMAG00000008476
Gene Symbol: JAK1
4 Cross references
236 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSUMAG00000016820
Gene Symbol: JAK2
4 Cross references
265 Possible Orthologues:

Janus Kinase 3

Ensembl ID : ENSUMAG00000009973
Gene Symbol: JAK3
4 Cross references
103 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSUMAG00000003838
Gene Symbol: KIT
4 Cross references
265 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).